Download PDF

Other users also viewed these articles

Implementation of the in-house technique for the determination of donor-derived cell-free DNA in daily clinical practice: Experience from the Hospital Clinic of Barcelona Elena Cuadrado-Payán; Eva González-Roca; Diana Rodríguez-Espinosa; Alicia Molina-Andújar; Enrique Montagud-Marrahi; Carolt Arana; Angela González-Rojas; Nuria Esforzado; Vicens Torregrosa; Pedro Ventura-Aguiar; María Argudo; Daniel Serrano-Jorcano; Maria José Ramírez-Bajo; Elisenda Bañón-Maneus; Silvia Casas; José Jesus Broseta; Joan Anton Puig-Butille; Ignacio Revuelta; Fritz Diekmann; David Cucchiari;
10.1016/j.nefroe.2025.03.004
Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients Luis Alberto Vigara; Florentino Villanego; Cristhian Orellana; Myriam Eady; María Gabriela Sánchez; Marta Alonso; María Belén García; José Manuel Amaro; Teresa García; Auxiliadora Mazuecos;
Nefrologia (English Version). 2024;44:885-93
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;
Nefrologia (English Version). 2024;44:204-16